CytomX Therapeutics, Inc.
CTMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001501989
No open-market purchases or sales by CytomX Therapeutics, Inc. insiders were filed in the last 90 days; 178 institutions reported holding it in 13F filings for Q2 2026, worth $799.0M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in CytomX Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 122
- −3 vs. Q1 2021
- Shares held
- 56.7M
- +2.09M (+3.8%) vs. Q1 2021
- Total value
- $358.9M
- −$63.1M (−15.0%) vs. Q1 2021
- New holders
- 14
- 56 more added
- Sold out
- 17
- 35 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 178 | $799.0M |
| Q1 2026 | 179 | $911.2M |
| Q4 2025 | 122 | $613.9M |
| Q3 2025 | 103 | $438.4M |
| Q2 2025 | 83 | $302.6M |
| Q1 2025 | 66 | $28.8M |
| Q4 2024 | 70 | $48.1M |
| Q3 2024 | 69 | $60.4M |
| Q2 2024 | 74 | $61.9M |
| Q1 2024 | 88 | $97.1M |
| Q4 2023 | 68 | $50.6M |
| Q3 2023 | 62 | $41.8M |
| Q2 2023 | 67 | $58.7M |
| Q1 2023 | 76 | $53.7M |
| Q4 2022 | 81 | $57.5M |
| Q3 2022 | 84 | $52.6M |
| Q2 2022 | 99 | $83.4M |
| Q1 2022 | 119 | $143.4M |
| Q4 2021 | 110 | $236.5M |
| Q3 2021 | 114 | $274.8M |
| Q2 2021 | 122 | $358.9M |
| Q1 2021 | 126 | $422.2M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding CytomX Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Squarepoint Ops LLC | 748,287 | $4.74M | 0.03% | +666,574+815.8% | Added |
| Citadel Advisors LLC | 769,766 | $4.87M | 0.01% | −160,144−17.2% | Reduced |
| Altium Capital Management LP | 862,417 | $5.46M | 1.27% | +379,376+78.5% | Added |
| Federated Hermes, Inc. | 932,007 | $5.90M | 0.01% | +338,586+57.1% | Added |
| Goldman Sachs Group Inc | 952,017 | $6.03M | 0.00% | +742,915+355.3% | Added |
| Great Point Partners LLC | 1,000,000 | $6.33M | 1.42% | +1,000,000 | New |
| Renaissance Technologies LLC | 1,026,200 | $6.50M | 0.01% | −426,368−29.4% | Reduced |
| FMR LLC | 1,045,620 | $6.62M | 0.00% | +130.0% | Added |
| Acadian Asset Management LLC | 1,049,139 | $6.64M | 0.02% | +102,178+10.8% | Added |
| Platinum Investment Management Ltd | 1,078,103 | $6.82M | 0.16% | +292,204+37.2% | Added |
| Geode Capital Management, LLC | 1,153,010 | $7.30M | 0.00% | +75,392+7.0% | Added |
| RTW Investments, LP | 1,400,939 | $8.87M | 0.13% | −132,819−8.7% | Reduced |
| Jacobs Levy Equity Management, Inc | 1,413,867 | $8.95M | 0.06% | +816,469+136.7% | Added |
| OrbiMed Advisors LLC | 1,513,168 | $9.58M | 0.10% | +1,513,168 | New |
| Perceptive Advisors LLC | 1,640,957 | $10.4M | 0.14% | −513,017−23.8% | Reduced |
| Candriam Luxembourg S.C.A. | 2,328,353 | $14.7M | 0.10% | +2,328,207+1,594,662.3% | Added |
| Victory Capital Management Inc | 2,868,986 | $18.2M | 0.02% | +100,104+3.6% | Added |
| Ra Capital Management, L.P. | 3,500,000 | $22.2M | 0.36% | 00.0% | Unchanged |
| State Street Corp | 4,616,562 | $29.2M | 0.00% | +1,257,697+37.4% | Added |
| BlackRock Inc. | 5,080,623 | $32.2M | 0.00% | −108,082−2.1% | Reduced |
| Vanguard Group Inc | 5,358,085 | $33.9M | 0.00% | +697,287+15.0% | Added |
| Point72 Asset Management, L.P. | 6,393,900 | $40.5M | 0.20% | +58,900+0.9% | Added |
| BVF Inc | 0 | $0 | 0.00% | −5,576,471−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −312,667−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −92,243−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −91,500−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −78,821−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −66,285−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −61,800−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −45,988−100.0% | Sold out |
| Quilter Plc | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −20,978−100.0% | Sold out |
| Congress Park Capital LLC | 0 | $0 | 0.00% | −20,207−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −19,093−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −17,345−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −16,827−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −13,810−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −10,100−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −3,806−100.0% | Sold out |
| WestHill Financial Advisors, Inc. | – | – | – | – | Not filed |